We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Stero Biotechs, in a collaboration with its main partner and shareholder, Mor Research Applications announced a new clinical trial in the global efforts of fighting the COVID-19 virus.
Stero Biotechs received its second Helsinki approval to move forward with a second Phase 2a clinical trial. The trial will be a randomized, double-blind, placebo-controlled, multicenter study of ST-SDCD-01 ...